www.fdanews.com/articles/133981-concert-pharmaceuticals-walter-reed-partner-on-seizure-treatment
Concert Pharmaceuticals, Walter Reed Partner on Seizure Treatment
February 3, 2011
Concert Pharmaceuticals Inc. announced that it has signed an agreement to work with the Walter Reed Army Institute of Research to conduct preclinical testing of a Concert drug compound in treating seizures stemming from traumatic brain injuries.
Mass High Tech
Mass High Tech